▶ 調査レポート

世界の分子診断システム市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Molecular Diagnostics Systems Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の分子診断システム市場 2021:企業別、地域別、種類・用途別 / Global Molecular Diagnostics Systems Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-107A13211資料のイメージです。• レポートコード:GIR-107A13211
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、分子診断システムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。分子診断システムの種類別市場規模(PCR、ハイブリダイゼーション、DNAシーケンシング)、用途別市場規模(病院、研究所)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・分子診断システムの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Abbott Laboratories、Qiagen N.V.、Roche Diagnostics、Hologic, Inc.、Grifols、Siemens Healthcare、Becton, Dickinson and Company、Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)、Biomérieux Sa、Cepheid Inc
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:PCR、ハイブリダイゼーション、DNAシーケンシング
・用途別分析2016年-2026年:病院、研究所
・分子診断システムの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・分子診断システムのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・分子診断システムのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・分子診断システムの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・分子診断システムの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Molecular Diagnostics Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Molecular Diagnostics Systems size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Molecular Diagnostics Systems market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Molecular Diagnostics Systems market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
PCR
Hybridization
DNA Sequencing

Market segment by Application can be divided into
Hospitals
Laboratories

The key market players for global Molecular Diagnostics Systems market are listed below:
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biomérieux Sa
Cepheid Inc

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Molecular Diagnostics Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Molecular Diagnostics Systems, with price, sales, revenue and global market share of Molecular Diagnostics Systems from 2019 to 2021.
Chapter 3, the Molecular Diagnostics Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Diagnostics Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Molecular Diagnostics Systems market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Molecular Diagnostics Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Molecular Diagnostics Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Molecular Diagnostics Systems Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 PCR
1.2.3 Hybridization
1.2.4 DNA Sequencing
1.3 Market Analysis by Application
1.3.1 Overview: Global Molecular Diagnostics Systems Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Laboratories
1.4 Global Molecular Diagnostics Systems Market Size & Forecast
1.4.1 Global Molecular Diagnostics Systems Sales in Value (2016-2026))
1.4.2 Global Molecular Diagnostics Systems Sales in Volume (2016-2026)
1.4.3 Global Molecular Diagnostics Systems Price by Type (2016-2026) & (USD/Unit)
1.5 Global Molecular Diagnostics Systems Production Capacity Analysis
1.5.1 Global Molecular Diagnostics Systems Total Production Capacity (2016-2026)
1.5.2 Global Molecular Diagnostics Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Molecular Diagnostics Systems Market Drivers
1.6.2 Molecular Diagnostics Systems Market Restraints
1.6.3 Molecular Diagnostics Systems Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Diagnostics Systems Product and Services
2.1.4 Abbott Laboratories Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Qiagen N.V.
2.2.1 Qiagen N.V. Details
2.2.2 Qiagen N.V. Major Business
2.2.3 Qiagen N.V. Molecular Diagnostics Systems Product and Services
2.2.4 Qiagen N.V. Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Molecular Diagnostics Systems Product and Services
2.3.4 Roche Diagnostics Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Hologic, Inc.
2.4.1 Hologic, Inc. Details
2.4.2 Hologic, Inc. Major Business
2.4.3 Hologic, Inc. Molecular Diagnostics Systems Product and Services
2.4.4 Hologic, Inc. Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Molecular Diagnostics Systems Product and Services
2.5.4 Grifols Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business
2.6.3 Siemens Healthcare Molecular Diagnostics Systems Product and Services
2.6.4 Siemens Healthcare Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Becton, Dickinson and Company
2.7.1 Becton, Dickinson and Company Details
2.7.2 Becton, Dickinson and Company Major Business
2.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Product and Services
2.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
2.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Details
2.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Major Business
2.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product and Services
2.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Biomérieux Sa
2.9.1 Biomérieux Sa Details
2.9.2 Biomérieux Sa Major Business
2.9.3 Biomérieux Sa Molecular Diagnostics Systems Product and Services
2.9.4 Biomérieux Sa Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Cepheid Inc
2.10.1 Cepheid Inc Details
2.10.2 Cepheid Inc Major Business
2.10.3 Cepheid Inc Molecular Diagnostics Systems Product and Services
2.10.4 Cepheid Inc Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Molecular Diagnostics Systems Sales by Manufacturer
3.1 Global Molecular Diagnostics Systems Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Molecular Diagnostics Systems Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Molecular Diagnostics Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Molecular Diagnostics Systems Manufacturer Market Share
3.4.2 Top 6 Molecular Diagnostics Systems Manufacturer Market Share
3.5 Global Molecular Diagnostics Systems Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Molecular Diagnostics Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Molecular Diagnostics Systems Market Size by Region
4.1.1 Global Molecular Diagnostics Systems Sales in Volume by Region (2016-2026)
4.1.2 Global Molecular Diagnostics Systems Revenue by Region (2016-2026)
4.2 North America Molecular Diagnostics Systems Revenue (2016-2026)
4.3 Europe Molecular Diagnostics Systems Revenue (2016-2026)
4.4 Asia-Pacific Molecular Diagnostics Systems Revenue (2016-2026)
4.5 South America Molecular Diagnostics Systems Revenue (2016-2026)
4.6 Middle East and Africa Molecular Diagnostics Systems Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Molecular Diagnostics Systems Sales in Volume by Type (2016-2026)
5.2 Global Molecular Diagnostics Systems Revenue by Type (2016-2026)
5.3 Global Molecular Diagnostics Systems Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Molecular Diagnostics Systems Sales in Volume by Application (2016-2026)
6.2 Global Molecular Diagnostics Systems Revenue by Application (2016-2026)
6.3 Global Molecular Diagnostics Systems Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Molecular Diagnostics Systems Sales by Type (2016-2026)
7.2 North America Molecular Diagnostics Systems Sales by Application (2016-2026)
7.3 North America Molecular Diagnostics Systems Market Size by Country
7.3.1 North America Molecular Diagnostics Systems Sales in Volume by Country (2016-2026)
7.3.2 North America Molecular Diagnostics Systems Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Molecular Diagnostics Systems Sales by Type (2016-2026)
8.2 Europe Molecular Diagnostics Systems Sales by Application (2016-2026)
8.3 Europe Molecular Diagnostics Systems Market Size by Country
8.3.1 Europe Molecular Diagnostics Systems Sales in Volume by Country (2016-2026)
8.3.2 Europe Molecular Diagnostics Systems Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Molecular Diagnostics Systems Sales by Type (2016-2026)
9.2 Asia-Pacific Molecular Diagnostics Systems Sales by Application (2016-2026)
9.3 Asia-Pacific Molecular Diagnostics Systems Market Size by Region
9.3.1 Asia-Pacific Molecular Diagnostics Systems Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Molecular Diagnostics Systems Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Molecular Diagnostics Systems Sales by Type (2016-2026)
10.2 South America Molecular Diagnostics Systems Sales by Application (2016-2026)
10.3 South America Molecular Diagnostics Systems Market Size by Country
10.3.1 South America Molecular Diagnostics Systems Sales in Volume by Country (2016-2026)
10.3.2 South America Molecular Diagnostics Systems Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Molecular Diagnostics Systems Sales by Type (2016-2026)
11.2 Middle East & Africa Molecular Diagnostics Systems Sales by Application (2016-2026)
11.3 Middle East & Africa Molecular Diagnostics Systems Market Size by Country
11.3.1 Middle East & Africa Molecular Diagnostics Systems Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Molecular Diagnostics Systems Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Molecular Diagnostics Systems Typical Distributors
12.3 Molecular Diagnostics Systems Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Molecular Diagnostics Systems Revenue by Type, (USD Million), 2021-2026
Table 2. Global Molecular Diagnostics Systems Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Molecular Diagnostics Systems Product and Services
Table 6. Abbott Laboratories Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 8. Qiagen N.V. Major Business
Table 9. Qiagen N.V. Molecular Diagnostics Systems Product and Services
Table 10. Qiagen N.V. Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 12. Roche Diagnostics Major Business
Table 13. Roche Diagnostics Molecular Diagnostics Systems Product and Services
Table 14. Roche Diagnostics Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hologic, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Hologic, Inc. Major Business
Table 17. Hologic, Inc. Molecular Diagnostics Systems Product and Services
Table 18. Hologic, Inc. Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Grifols Basic Information, Manufacturing Base and Competitors
Table 20. Grifols Major Business
Table 21. Grifols Molecular Diagnostics Systems Product and Services
Table 22. Grifols Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Siemens Healthcare Major Business
Table 25. Siemens Healthcare Molecular Diagnostics Systems Product and Services
Table 26. Siemens Healthcare Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 28. Becton, Dickinson and Company Major Business
Table 29. Becton, Dickinson and Company Molecular Diagnostics Systems Product and Services
Table 30. Becton, Dickinson and Company Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Basic Information, Manufacturing Base and Competitors
Table 32. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Major Business
Table 33. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product and Services
Table 34. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biomérieux Sa Basic Information, Manufacturing Base and Competitors
Table 36. Biomérieux Sa Major Business
Table 37. Biomérieux Sa Molecular Diagnostics Systems Product and Services
Table 38. Biomérieux Sa Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cepheid Inc Basic Information, Manufacturing Base and Competitors
Table 40. Cepheid Inc Major Business
Table 41. Cepheid Inc Molecular Diagnostics Systems Product and Services
Table 42. Cepheid Inc Molecular Diagnostics Systems Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Molecular Diagnostics Systems Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Molecular Diagnostics Systems Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Molecular Diagnostics Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Molecular Diagnostics Systems Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Molecular Diagnostics Systems Production Site of Key Manufacturer
Table 48. Molecular Diagnostics Systems New Entrant and Capacity Expansion Plans
Table 49. Molecular Diagnostics Systems Mergers & Acquisitions in the Past Five Years
Table 50. Global Molecular Diagnostics Systems Sales by Region (2016-2021e) & (K Units)
Table 51. Global Molecular Diagnostics Systems Sales by Region (2021-2026) & (K Units)
Table 52. Global Molecular Diagnostics Systems Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Molecular Diagnostics Systems Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Molecular Diagnostics Systems Sales by Type (2016-2021e) & (K Units)
Table 55. Global Molecular Diagnostics Systems Sales by Type (2021-2026) & (K Units)
Table 56. Global Molecular Diagnostics Systems Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Molecular Diagnostics Systems Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Molecular Diagnostics Systems Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Molecular Diagnostics Systems Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Molecular Diagnostics Systems Sales by Application (2016-2021e) & (K Units)
Table 61. Global Molecular Diagnostics Systems Sales by Application (2021-2026) & (K Units)
Table 62. Global Molecular Diagnostics Systems Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Molecular Diagnostics Systems Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Molecular Diagnostics Systems Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Molecular Diagnostics Systems Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Molecular Diagnostics Systems Sales by Country (2016-2021e) & (K Units)
Table 67. North America Molecular Diagnostics Systems Sales by Country (2021-2026) & (K Units)
Table 68. North America Molecular Diagnostics Systems Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Molecular Diagnostics Systems Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Molecular Diagnostics Systems Sales by Type (2016-2021e) & (K Units)
Table 71. North America Molecular Diagnostics Systems Sales by Type (2021-2026) & (K Units)
Table 72. North America Molecular Diagnostics Systems Sales by Application (2016-2021e) & (K Units)
Table 73. North America Molecular Diagnostics Systems Sales by Application (2021-2026) & (K Units)
Table 74. Europe Molecular Diagnostics Systems Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Molecular Diagnostics Systems Sales by Country (2021-2026) & (K Units)
Table 76. Europe Molecular Diagnostics Systems Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Molecular Diagnostics Systems Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Molecular Diagnostics Systems Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Molecular Diagnostics Systems Sales by Type (2021-2026) & (K Units)
Table 80. Europe Molecular Diagnostics Systems Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Molecular Diagnostics Systems Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Molecular Diagnostics Systems Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Molecular Diagnostics Systems Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Molecular Diagnostics Systems Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Molecular Diagnostics Systems Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Molecular Diagnostics Systems Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Molecular Diagnostics Systems Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Molecular Diagnostics Systems Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Molecular Diagnostics Systems Sales by Application (2021-2026) & (K Units)
Table 90. South America Molecular Diagnostics Systems Sales by Country (2016-2021e) & (K Units)
Table 91. South America Molecular Diagnostics Systems Sales by Country (2021-2026) & (K Units)
Table 92. South America Molecular Diagnostics Systems Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Molecular Diagnostics Systems Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Molecular Diagnostics Systems Sales by Type (2016-2021e) & (K Units)
Table 95. South America Molecular Diagnostics Systems Sales by Type (2021-2026) & (K Units)
Table 96. South America Molecular Diagnostics Systems Sales by Application (2016-2021e) & (K Units)
Table 97. South America Molecular Diagnostics Systems Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Molecular Diagnostics Systems Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Molecular Diagnostics Systems Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Molecular Diagnostics Systems Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Molecular Diagnostics Systems Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Molecular Diagnostics Systems Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Molecular Diagnostics Systems Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Molecular Diagnostics Systems Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Molecular Diagnostics Systems Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Molecular Diagnostics Systems Typical Distributors
Table 109. Molecular Diagnostics Systems Typical Customers
List of Figures
Figure 1. Molecular Diagnostics Systems Picture
Figure 2. Global Molecular Diagnostics Systems Sales Market Share by Type in 2020
Figure 3. PCR
Figure 4. Hybridization
Figure 5. DNA Sequencing
Figure 6. Global Molecular Diagnostics Systems Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Laboratories
Figure 9. Global Molecular Diagnostics Systems Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Molecular Diagnostics Systems Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Molecular Diagnostics Systems Sales (2016-2026) & (K Units)
Figure 12. Global Molecular Diagnostics Systems Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Molecular Diagnostics Systems Production Capacity (2016-2026) & (K Units)
Figure 14. Global Molecular Diagnostics Systems Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Molecular Diagnostics Systems Market Drivers
Figure 16. Molecular Diagnostics Systems Market Restraints
Figure 17. Molecular Diagnostics Systems Market Trends
Figure 18. Global Molecular Diagnostics Systems Sales Market Share by Manufacturer in 2020
Figure 19. Global Molecular Diagnostics Systems Revenue Market Share by Manufacturer in 2020
Figure 20. Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Molecular Diagnostics Systems Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Molecular Diagnostics Systems Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Molecular Diagnostics Systems Sales Market Share by Region (2016-2026)
Figure 24. Global Molecular Diagnostics Systems Revenue Market Share by Region (2016-2026)
Figure 25. North America Molecular Diagnostics Systems Revenue (2016-2026) & (USD Million)
Figure 26. Europe Molecular Diagnostics Systems Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Molecular Diagnostics Systems Revenue (2016-2026) & (USD Million)
Figure 28. South America Molecular Diagnostics Systems Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Molecular Diagnostics Systems Revenue (2016-2026) & (USD Million)
Figure 30. Global Molecular Diagnostics Systems Sales Market Share by Type (2016-2026)
Figure 31. Global Molecular Diagnostics Systems Revenue Market Share by Type (2016-2026)
Figure 32. Global Molecular Diagnostics Systems Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Molecular Diagnostics Systems Sales Market Share by Application (2016-2026)
Figure 34. Global Molecular Diagnostics Systems Revenue Market Share by Application (2016-2026)
Figure 35. Global Molecular Diagnostics Systems Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Molecular Diagnostics Systems Sales Market Share by Type (2016-2026)
Figure 37. North America Molecular Diagnostics Systems Sales Market Share by Application (2016-2026)
Figure 38. North America Molecular Diagnostics Systems Sales Market Share by Country (2016-2026)
Figure 39. North America Molecular Diagnostics Systems Revenue Market Share by Country (2016-2026)
Figure 40. United States Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Molecular Diagnostics Systems Sales Market Share by Type (2016-2026)
Figure 44. Europe Molecular Diagnostics Systems Sales Market Share by Application (2016-2026)
Figure 45. Europe Molecular Diagnostics Systems Sales Market Share by Country (2016-2026)
Figure 46. Europe Molecular Diagnostics Systems Revenue Market Share by Country (2016-2026)
Figure 47. Germany Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Molecular Diagnostics Systems Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Molecular Diagnostics Systems Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Molecular Diagnostics Systems Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Molecular Diagnostics Systems Revenue Market Share by Region (2016-2026)
Figure 56. China Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Molecular Diagnostics Systems Sales Market Share by Type (2016-2026)
Figure 63. South America Molecular Diagnostics Systems Sales Market Share by Application (2016-2026)
Figure 64. South America Molecular Diagnostics Systems Sales Market Share by Country (2016-2026)
Figure 65. South America Molecular Diagnostics Systems Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Molecular Diagnostics Systems Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Molecular Diagnostics Systems Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Molecular Diagnostics Systems Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Molecular Diagnostics Systems Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Molecular Diagnostics Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source